Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Low-level viremia and intracellular expression of hepatitis B surface antigen (HBsAg) in HBsAg carriers with concurrent hepatitis C virus infection.

Literature DB >> 9650968

Low-level viremia and intracellular expression of hepatitis B surface antigen (HBsAg) in HBsAg carriers with concurrent hepatitis C virus infection.

Abstract

Assays of hepatitis B virus (HBV) replication and antigen expression in HBV surface antigen (HBsAg) carriers with concurrent hepatitis C or D virus (HCV or HDV) infection revealed that HCV and HDV can suppress HBV replication but that HCV also substantially suppresses HBV surface protein expression. HBsAg carriers with concurrent HCV infection thus have low-level viremia and intracellular HBsAg.

Entities: Disease Species

Mesh：

Substances：

Year: 1998 PMID： 9650968 PMCID： PMC104984

Source DB: PubMed Journal: J Clin Microbiol ISSN： 0095-1137 Impact factor: 5.948

22 in total

1. Correlation of hepatocyte HBsAg expression with virus replication and liver pathology.

Authors: H C Hsu; M Y Lai; I J Su; D S Chen; M H Chang; P M Yang; C Y Wu; H C Hsieh
Journal: Hepatology Date: 1988 Jul-Aug Impact factor: 17.425

2. Intrahepatic distribution of hepatitis B surface and core antigens in chronic hepatitis B virus infection. Hepatocyte with cytoplasmic/membranous hepatitis B core antigen as a possible target for immune hepatocytolysis.

Authors: C M Chu; Y F Liaw
Journal: Gastroenterology Date: 1987-01 Impact factor: 22.682

3. Transmission of the hepatitis B virus-associated delta antigen to chimpanzees.

Authors: M Rizzetto; M G Canese; J L Gerin; W T London; D L Sly; R H Purcell
Journal: J Infect Dis Date: 1980-05 Impact factor: 5.226

4. Prevalence and significance of hepatitis C viremia in chronic active hepatitis B.

Authors: J Crespo; J L Lozano; F de la Cruz; L Rodrigo; M Rodríguez; G San Miguel; E Artiñano; F Pons-Romero
Journal: Am J Gastroenterol Date: 1994-08 Impact factor: 10.864

5. Serum levels of hepatitis B surface and core antigens during immunosuppressive treatment of HBsAg-positive chronic active hepatitis.

Authors: E Sagnelli; G Manzillo; G Maio; G Pasquale; F M Felaco; P Filippini; C M Izzo; F Piccinino
Journal: Lancet Date: 1980-08-23 Impact factor: 79.321

6. Clinical aspects of delta infection.

Authors: T Moestrup; B G Hansson; A Widell; E Nordenfelt
Journal: Br Med J (Clin Res Ed) Date: 1983-01-08

7. Membrane staining for hepatitis B surface antigen on hepatocytes: a sensitive and specific marker of active viral replication in hepatitis B.

Authors: C M Chu; Y F Liaw
Journal: J Clin Pathol Date: 1995-05 Impact factor: 3.411

8. Subcellular localization of hepatitis B core antigen in relation to hepatocyte regeneration in chronic hepatitis B.

Authors: C M Chu; C T Yeh; I S Sheen; Y F Liaw
Journal: Gastroenterology Date: 1995-12 Impact factor: 22.682

9. Hepatitis C virus antibody and hepatitis C virus replication in chronic hepatitis B patients.

Authors: K Ohkawa; N Hayashi; N Yuki; H Hagiwara; M Kato; K Yamamoto; H Eguchi; H Fusamoto; M Masuzawa; T Kamada
Journal: J Hepatol Date: 1994-10 Impact factor: 25.083

10. Coinfection of hepatitis C virus in patients with chronic hepatitis B infection.

Authors: S Sato; S Fujiyama; M Tanaka; K Yamasaki; I Kuramoto; S Kawano; T Sato; K Mizuno; S Nonaka
Journal: J Hepatol Date: 1994-08 Impact factor: 25.083

24 in total

Review 1. Isolated anti-HBc: The Relevance of Hepatitis B Core Antibody-A Review of New Issues.

Authors: Tiffany Wu; Ryan M Kwok; Tram T Tran
Journal: Am J Gastroenterol Date: 2017-10-31 Impact factor: 10.864

2. Parasite interactions in natural populations: insights from longitudinal data.

Authors: S Telfer; R Birtles; M Bennett; X Lambin; S Paterson; M Begon
Journal: Parasitology Date: 2008-05-12 Impact factor: 3.234

Review 3. Hepatitis B reactivation during or after direct acting antiviral therapy - implication for susceptible individuals.

Authors: Jacinta A Holmes; Ming-Lung Yu; Raymond T Chung
Journal: Expert Opin Drug Saf Date: 2017-05-19 Impact factor: 4.250

Review 4. MiR-122 in hepatitis B virus and hepatitis C virus dual infection.

Authors: Kyoungsub Song; Chang Han; Srikanta Dash; Luis A Balart; Tong Wu
Journal: World J Hepatol Date: 2015-03-27

5. Caution: Reactivation of Hepatitis B during Hepatitis C Treatment with Direct-Acting Antiviral Therapy.

Authors: Anjana A Pillai; Frank A Anania; Brian L Pearlman
Journal: Am J Gastroenterol Date: 2016-12 Impact factor: 10.864

6. Dual chronic hepatitis B virus and hepatitis C virus infection.

Authors: Chun-Jen Liu; Pei-Jer Chen; Ding-Shinn Chen
Journal: Hepatol Int Date: 2009-08-08 Impact factor: 6.047

7. Relationship of hepatitis B virus infection to the recurrence of hepatocellular carcinoma after direct acting antivirals.

Authors: Hirohito Shimizu; Keiji Matsui; Shogo Iwabuchi; Tomoaki Fujikawa; Mitsuru Nagata; Kentaro Takatsuka; Hiroyuki Tanemura; Haruhiro Nakazaki; Masayuki Nakano; Tsunamasa Watanabe
Journal: Indian J Gastroenterol Date: 2017-05-30

8. Limited hepatitis B virus replication space in the chronically hepatitis C virus-infected liver.

Authors: S F Wieland; S Asabe; R E Engle; R H Purcell; F V Chisari
Journal: J Virol Date: 2014-02-12 Impact factor: 5.103

Review 9. Hepatitis C virus superinfection in patients with chronic hepatitis B virus infection.

Authors: Yun-Fan Liaw
Journal: J Gastroenterol Date: 2002 Impact factor: 7.527

10. Acute hepatitis C virus (HCV) infection in chronic carriers of hepatitis B virus (HBV): the impact of underlying active HBV replication on persistence of HCV infection and antibody responses to HCV.

Authors: C-M Chu; C T Yeh; I S Sheen; Y F Liaw
Journal: Gut Date: 2002-07 Impact factor: 23.059